Transient natural killer cell dysfunction associated with interleukin‐18 overproduction in systemic juvenile idiopathic arthritis
Authors:
- 21 October 2018
- journal article
- editorial
- Published by Wiley in Pediatrics International
- Vol. 60 (10) , 984-985
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritisClinical Immunology, 2015
- An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndromeNature Genetics, 2014
- Defective phosphorylation of interleukin‐18 receptor β causes impaired natural killer cell function in systemic‐onset juvenile idiopathic arthritisArthritis & Rheumatism, 2009
- Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced CancerClinical Cancer Research, 2006
- Natural killer cell dysfunction: A common pathway in systemic‐onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?Arthritis & Rheumatism, 2004